Advertisement 2 Story continues below This advertisement has not loaded yet, but your article continues below. Try refreshing your browser, or WHO rejects Medicago vaccine funded by $173 million from Trudeau government Back to video Known as Covifenz, the vaccine was developed by Medicago, a biotechnology company based in Quebec City that uses — unlike mRNA technology — a plant host to make virus-like particles that help the body’s immune system make antibodies. “We are aware that the WHO updated Medicago’s vaccine status to ‘not accepted’, Medicago President Takashi Nagao told Global News on Friday. Advertisement 3 Story continues below This advertisement has not loaded yet, but your article continues below. Share this article in your social networkAdvertisement Story continues below This advertisement has not loaded yet, but your article continues below.

Source: National Post March 26, 2022 04:04 UTC